• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马里科洛卡尼地区实施磺胺多辛-乙胺嘧啶间歇性预防治疗婴儿疟疾后,EPI 疫苗覆盖率增加:一项整群随机对照试验的结果。

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.

机构信息

Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, University of Bamako, Mali.

出版信息

BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573.

DOI:10.1186/1471-2458-11-573
PMID:21767403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3155918/
Abstract

BACKGROUND

Even though the efficacy of Intermittent Preventive Treatment in infants (IPTi) with Sulfadoxine-Pyrimethamine (SP) against clinical disease and the absence of its interaction with routine vaccines of the Expanded Immunization Programme (EPI) have been established, there are still some concerns regarding the addition of IPTi, which may increase the work burden and disrupt the routine EPI services especially in Africa where the target immunization coverage remains to be met. However IPTi may also increase the adherence of the community to EPI services and improve EPI coverage, once the benefice of strategy is perceived.

METHODS

To assess the impact of IPTi implementation on the coverage of EPI vaccines, 22 health areas of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The EPI vaccines coverage was assessed using cross-sectional surveys at baseline in November 2006 and after one year of IPTi pilot-implementation in December 2007.

RESULTS

At baseline, the proportion of children of 9-23 months who were completely vaccinated (defined as children who received BGG, 3 doses of DTP/Polio, measles and yellow fever vaccines) was 36.7% (95% CI 25.3% -48.0%). After one year of implementation of IPTi-SP using routine health services, the proportion of children completely vaccinated rose to 53.8% in the non intervention zone and 69.5% in the IPTi intervention zone (P <0.001).The proportion of children in the target age groups who received IPTi with each of the 3 vaccinations DTP2, DTP3 and Measles, were 89.2% (95% CI 85.9%-92.0%), 91.0% (95% CI 87.6% -93.7%) and 77.4% (95% CI 70.7%-83.2%) respectively. The corresponding figures in non intervention zone were 2.3% (95% CI 0.9% -4.7%), 2.6% (95% CI 1.0% -5.6%) and 1.7% (95% CI 0.4% - 4.9%).

CONCLUSION

This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation results in a significant increase in coverage of EPI vaccines in the district of Kolokani, Mali.

摘要

背景

虽然磺胺多辛-乙胺嘧啶间歇性预防疗法(IPTi)对婴儿的临床疾病疗效以及与扩大免疫规划(EPI)常规疫苗无相互作用已经得到证实,但在非洲,添加 IPTi 仍存在一些担忧,因为这可能会增加工作负担并扰乱常规 EPI 服务,特别是在目标免疫覆盖率仍有待达到的地区。然而,一旦认识到该策略的益处,IPTi 还可能提高社区对 EPI 服务的依从性并提高 EPI 覆盖率。

方法

为了评估 IPTi 实施对 EPI 疫苗覆盖率的影响,将科洛卡尼区的 22 个卫生区按 1:1 的比例随机分配,分别接受 IPTi-SP 或作为对照。使用横断面调查在 2006 年 11 月基线时和 2007 年 12 月 IPTi 试点实施一年后评估 EPI 疫苗覆盖率。

结果

在基线时,9-23 个月龄儿童完全接种疫苗的比例(定义为接受 BGG、3 剂 DTP/脊髓灰质炎、麻疹和黄热病疫苗的儿童)为 36.7%(95%CI 25.3%-48.0%)。在使用常规卫生服务实施 IPTi-SP 一年后,非干预区儿童完全接种疫苗的比例上升至 53.8%,干预区上升至 69.5%(P<0.001)。在目标年龄组中,接受每剂 DTP2、DTP3 和麻疹疫苗的儿童中,接受 IPTi 的比例分别为 89.2%(95%CI 85.9%-92.0%)、91.0%(95%CI 87.6%-93.7%)和 77.4%(95%CI 70.7%-83.2%)。非干预区的相应数字分别为 2.3%(95%CI 0.9%-4.7%)、2.6%(95%CI 1.0%-5.6%)和 1.7%(95%CI 0.4%-4.9%)。

结论

本研究表明,当使用常规卫生服务实施该策略时,可获得较高的 IPTi 覆盖率,并且该策略在科洛卡尼区实施后,EPI 疫苗覆盖率显著提高。

相似文献

1
Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.在马里科洛卡尼地区实施磺胺多辛-乙胺嘧啶间歇性预防治疗婴儿疟疾后,EPI 疫苗覆盖率增加:一项整群随机对照试验的结果。
BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573.
2
Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.婴儿期间歇性预防治疗疟疾对扩大免疫规划中使用的麻疹和其他疫苗血清学反应的影响:五项随机对照试验的结果。
Lancet. 2012 Sep 15;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2. Epub 2012 Jul 30.
3
The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control.在马里科洛卡尼地区,对婴儿采用磺胺多辛-乙胺嘧啶进行疟疾间歇性预防治疗(IPT)降低了全因死亡率:一项基于群组的随机对照研究结果。
Malar J. 2012 Mar 16;11:73. doi: 10.1186/1475-2875-11-73.
4
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.分子标志物对磺胺多辛-乙胺嘧啶耐药性的影响:在马里实施婴儿间歇性预防治疗疟疾一年后。
Malar J. 2010 Jan 10;9:9. doi: 10.1186/1475-2875-9-9.
5
Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.在三个非洲法语国家中,将婴幼儿间歇性预防治疗与扩大免疫规划相结合的可接受性。
Trop Med Int Health. 2012 Mar;17(3):308-15. doi: 10.1111/j.1365-3156.2011.02915.x. Epub 2011 Nov 29.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.模拟婴幼儿间歇性预防治疗疟疾的替代给药方案的保护效果。
PLoS One. 2011 Apr 20;6(4):e18947. doi: 10.1371/journal.pone.0018947.
8
Intermittent preventive treatment for malaria in infants.婴儿疟疾的间歇性预防治疗
Cochrane Database Syst Rev. 2021 Jul 17;7(7):CD011525. doi: 10.1002/14651858.CD011525.pub3.
9
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.磺胺多辛-乙胺嘧啶间歇性预防治疗对非洲婴儿疟疾的疗效和安全性:六项随机、安慰剂对照试验的汇总分析
Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Epub 2009 Sep 16.
10
The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.马里提高孕妇间歇性预防疟疾治疗覆盖率的提供者清单:试点实施研究。
Malar J. 2021 Oct 16;20(1):402. doi: 10.1186/s12936-021-03940-7.

引用本文的文献

1
Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011-2020.低收入和中等收入国家将孕产妇和儿童保健服务与儿童免疫规划相结合的综合方法:2011 - 2020年系统评价更新
Vaccines (Basel). 2024 Nov 23;12(12):1313. doi: 10.3390/vaccines12121313.
2
Interventions addressing routine childhood immunization and its behavioral and social drivers.针对常规儿童免疫接种及其行为和社会驱动因素的干预措施。
Front Public Health. 2024 Jun 19;12:1364798. doi: 10.3389/fpubh.2024.1364798. eCollection 2024.
3
Contextual Factors to Improve Implementation of Malaria Chemoprevention in Children: A Systematic Review.改善儿童疟疾化学预防实施的背景因素:系统评价。
Am J Trop Med Hyg. 2023 Dec 11;110(1):69-78. doi: 10.4269/ajtmh.23-0478. Print 2024 Jan 3.
4
Interventions for improving coverage of childhood immunisation in low- and middle-income countries.改善中低收入国家儿童免疫接种覆盖率的干预措施。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD008145. doi: 10.1002/14651858.CD008145.pub4.
5
Perennial malaria chemoprevention with and without malaria vaccination to reduce malaria burden in young children: a modelling analysis.有/无疟疾疫苗接种的疟疾常年化学预防以减少幼儿疟疾负担:建模分析。
Malar J. 2023 Apr 24;22(1):133. doi: 10.1186/s12936-023-04564-9.
6
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
7
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.接种人员到达接种点的成本系统评价:为覆盖难以触及的人群而增加的成本。
Vaccine. 2021 Jul 30;39(33):4598-4610. doi: 10.1016/j.vaccine.2021.05.019. Epub 2021 Jul 6.
8
Perception of Malaria Chemoprevention Interventions in Infants and Children in Eight Sub-Saharan African Countries: An End User Perspective Study.撒哈拉以南非洲八个国家婴幼儿疟疾化学预防干预措施的认知:一项终端用户视角研究
Trop Med Infect Dis. 2021 May 11;6(2):75. doi: 10.3390/tropicalmed6020075.
9
Realist Synthesis of the International Theory and Evidence on Strategies to Improve Childhood Vaccination in Low- and Middle-Income Countries: Developing Strategies for the Nigerian Healthcare System.国际理论与低中收入国家改善儿童疫苗接种策略证据的现实主义综合研究:为尼日利亚医疗保健系统制定策略。
Int J Health Policy Manag. 2020 Jul 1;9(7):274-285. doi: 10.15171/ijhpm.2019.120.
10
Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial.奥伊勒塞布古季节性疟疾化学预防的最佳投放模式:一项整群随机试验。
PLoS One. 2018 Mar 5;13(3):e0193296. doi: 10.1371/journal.pone.0193296. eCollection 2018.

本文引用的文献

1
Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.疟疾间歇性预防治疗在婴儿中的药物警戒与 6 个非洲国家常规免疫相结合。
J Infect Dis. 2012 Mar;205 Suppl 1:S82-90. doi: 10.1093/infdis/jir799.
2
Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.在三个非洲法语国家中,将婴幼儿间歇性预防治疗与扩大免疫规划相结合的可接受性。
Trop Med Int Health. 2012 Mar;17(3):308-15. doi: 10.1111/j.1365-3156.2011.02915.x. Epub 2011 Nov 29.
3
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial.在马里,间歇性预防治疗疟疾为已经使用驱虫蚊帐保护的儿童提供了针对疟疾的实质性保护:一项随机、双盲、安慰剂对照试验。
PLoS Med. 2011 Feb 1;8(2):e1000407. doi: 10.1371/journal.pmed.1000407.
4
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.撒哈拉以南非洲婴幼儿疟疾间歇性预防治疗的成本效益。
PLoS One. 2010 Jun 15;5(6):e10313. doi: 10.1371/journal.pone.0010313.
5
Implementing intermittent preventive treatment in infants.在婴儿中实施间歇性预防治疗。
Lancet. 2010 Jan 9;375(9709):121. doi: 10.1016/S0140-6736(10)60047-5.
6
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.分子标志物对磺胺多辛-乙胺嘧啶耐药性的影响:在马里实施婴儿间歇性预防治疗疟疾一年后。
Malar J. 2010 Jan 10;9:9. doi: 10.1186/1475-2875-9-9.
7
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations.免疫战略咨询专家组会议,2009年10月——结论与建议
Wkly Epidemiol Rec. 2009 Dec 11;84(50):517-32.
8
Evaluation of immunization coverage within the Expanded Program on Immunization in Kita Circle, Mali: a cross-sectional survey.马里基塔区扩大免疫规划内免疫接种覆盖率评估:一项横断面调查
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1(Suppl 1):S13. doi: 10.1186/1472-698X-9-S1-S13.
9
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.磺胺多辛-乙胺嘧啶间歇性预防治疗对非洲婴儿疟疾的疗效和安全性:六项随机、安慰剂对照试验的汇总分析
Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Epub 2009 Sep 16.
10
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.三种抗疟方案用于婴儿疟疾间歇性预防治疗的保护效果及安全性:一项随机、双盲、安慰剂对照试验
Lancet. 2009 Oct 31;374(9700):1521-32. doi: 10.1016/S0140-6736(09)60997-1. Epub 2009 Sep 16.